|
(Health-NewsWire.Net, July 23, 2015 ) Low Back Pain - Pipeline Review, H1 2015
RnRMarketResearch.com Adds Low Back Pain - Pipeline Review, H1 2015 which provides an overview of the Low Back Pain therapeutic pipeline.
This report gives extensive data on the restorative advancement for Low Back Pain, complete with near examination at different stages, therapeutics evaluation by medication target, instrument of activity (MoA), course of organization (RoA) and atom sort, alongside most recent upgrades, and highlighted news and press discharges. It likewise audits key players included in the remedial advancement for Low Back Pain and extraordinary elements on late-stage and ended undertakings.
The report improves choice making capacities and help to make successful counter techniques to increase upper hand. It reinforces R&D pipelines by recognizing new targets and MOAs to deliver first-in-class and best-in-class items.
Complete report on H1, 2015 Pipeline Review of Low Back Pain addition with 35 market data tables and 15 figures, spread across 101 pages is http://www.rnrmarketresearch.com/low-back-pain-pipeline-review-h1-2015-market-report.html .
This report highlights investigational medications from crosswise over globe covering more than 20 treatment regions and about 3,000 evidences. The report is assembled utilizing information and data sourced from our restrictive databases, Company/University sites, SEC filings, financial specialist presentations and included press discharges from organization/college locales and industry-particular outsider sources, set up together by Global Markets Direct's group. Medication profiles/records highlighted in the report experiences occasional updation taking after a stringent arrangement of procedures that guarantees that every one of the profiles are overhauled with the most recent arrangement of data. Moreover, procedures including live news & arrangements following, program based ready box and clinical trials registries following guarantee that the latest improvements are caught on an ongoing premise.
Drugs Profile Discussed in this Research :
(acetaminophen + tramadol hydrochloride), (diclofenac sodium + eperisone), (etodolac + lidocaine), (etoricoxib + tizanidine), (oxycodone hydrochloride + naltrexone) ER, AB-001, abobotulinumtoxin A, ASP-7962, Atx09-002, bupivacaine hydrochloride, cebranopadol, Drug for Chronic Low Back Pain duloxetine hydrochloride DR, eperisone SR, flurbiprofen sodium, MPC-06ID, NKTR-181, oxycodone hydrochloride ER, and PF-06372865
Companies Discussed/Mentioned in this Research:
Aestus Therapeutics, Inc., Astellas Pharma Inc., Collegium Pharmaceutical, Inc., Eisai Co., Ltd., Eli Lilly and Company, Frontier Biotechnologies Co., Ltd, Grunenthal GmbH, Ipsen S.A., MEDRx Co., Ltd., Merck & Co., Inc., Mesoblast Limited, Nektar Therapeutics, Pacira Pharmaceuticals, Inc., Paladin Labs Inc., Pfizer Inc., Stayble Therapeutics and Teikoku Pharma USA, Inc.
Inquire before buying for this report http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=395220 . (This is a premium report price at US$2000 for a single user PDF license)
Scope :
The report provides a snapshot of the global therapeutic landscape of Low Back Pain
The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
The report reviews key players involved in the therapeutics development for Low Back Pain and enlists all their major and minor projects
The report summarizes all the dormant and discontinued pipeline projects
A review of the Low Back Pain products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
A detailed assessment of monotherapy and combination therapy pipeline projects
Coverage of the Low Back Pain pipeline on the basis of target, MoA, route of administration and molecule type
Latest news and deals relating related to pipeline products
Reasons to buy :
Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop strategic initiatives by understanding the focus areas of leading companies
Identify and understand important and diverse types of therapeutics under development for Low Back Pain
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Devise corrective measures for pipeline projects by understanding Low Back Pain pipeline depth and focus of Indication therapeutics
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Explore More Research Report on Therapeutics Market.
There has been a great revolution that has been experienced in the field of medical science to make healthy living possible. The contribution of the so much research in the field of therapeutics is noteworthy in this regard. By definition, therapeutics is the field of medical science that deals with the various therapies that can help to cure the disease and pain. In fact, there are different therapies that exist and can provide the treatment in a non-surgical manner. Fighting with the worst of the diseases is only possible with the help of the so much innovation in the field of therapeutics.
About Us:
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
RnR Market Research
Ritesh Tiwari
+ 18883915441
sales@rnrmarketresearch.com
Source: EmailWire.Com 
|
